💡
💡 Did You Know
Jennifer Doudna on CRISPR: major breakthroughs and unfulfilled hopes
Fourteen years after co-inventing CRISPR, Jennifer Doudna assesses the technology's achievements: from its 2012 discovery, through the controversial "CRISPR babies" in 2018, to sickle cell disease therapy costing $2 million. The Nobel laureate emphasizes that the price still excludes most patients from accessing treatment. She also mentions new applications, such as reducing methane emissions from cows. She admits that the technology is like a genie released from a bottle — it cannot be put back, and its responsible direction remains an open challenge.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!